Designing clinical trials for combination immunotherapy: a framework for glioblastoma
Immunotherapy has revolutionized treatment for many hard-to-treat cancers but has yet to produce significant improvement in outcomes for patients with glioblastoma. This reflects the multiple and unique mechanisms of immune evasion and escape in this highly heterogeneous tumor. Glioblastoma engender...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 February 2022
|
| In: |
Clinical cancer research
Year: 2022, Jahrgang: 28, Heft: 4, Pages: 585-593 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-21-2681 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-21-2681 Verlag, lizenzpflichtig, Volltext: https://aacrjournals.org/clincancerres/article/28/4/585/678113/Designing-Clinical-Trials-for-Combination 
|
| Verfasserangaben: | Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi, Michael Weller, Amy B. Heimberger, and Mustafa Khasraw |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1889905100 | ||
| 003 | DE-627 | ||
| 005 | 20240703182157.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240527s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-21-2681 |2 doi | |
| 035 | |a (DE-627)1889905100 | ||
| 035 | |a (DE-599)KXP1889905100 | ||
| 035 | |a (OCoLC)1443679080 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Singh, Kirit |e VerfasserIn |0 (DE-588)1330852303 |0 (DE-627)1889905798 |4 aut | |
| 245 | 1 | 0 | |a Designing clinical trials for combination immunotherapy |b a framework for glioblastoma |c Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi, Michael Weller, Amy B. Heimberger, and Mustafa Khasraw |
| 264 | 1 | |c 15 February 2022 | |
| 300 | |b Illustrationen | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.05.2024 | ||
| 520 | |a Immunotherapy has revolutionized treatment for many hard-to-treat cancers but has yet to produce significant improvement in outcomes for patients with glioblastoma. This reflects the multiple and unique mechanisms of immune evasion and escape in this highly heterogeneous tumor. Glioblastoma engenders profound local and systemic immunosuppression and is remarkably effective at inducing T-cell dysfunction, posing a challenge to any immunotherapy-based approach. To overcome these mechanisms, multiple disparate modes of immune-oriented therapy will be required. However, designing trials that can evaluate these combinatorial approaches requires careful consideration. In this review, we explore the immunotherapy resistance mechanisms that have been encountered to date and how combinatorial approaches may address these. We also describe the unique aspects of trial design in both preclinical and clinical settings and consider endpoints and markers of response best suited for an intervention involving multiple agents. | ||
| 700 | 1 | |a Batich, Kristen A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wen, Patrick Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tan, Aaron C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bagley, Stephen J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lim, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Platten, Michael |d 1971- |e VerfasserIn |0 (DE-588)121627780 |0 (DE-627)081431848 |0 (DE-576)261969811 |4 aut | |
| 700 | 1 | |a Colman, Howard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ashley, David M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chang, Susan M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rahman, Rifaquat |e VerfasserIn |4 aut | |
| 700 | 1 | |a Galanis, Evanthia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mansouri, Alireza |e VerfasserIn |4 aut | |
| 700 | 1 | |a Puduvalli, Vinay K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reardon, David A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sahebjam, Solmaz |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sampson, John H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Simes, John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berry, Donald A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zadeh, Gelareh |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cloughesy, Tim F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mehta, Minesh P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Piantadosi, Steven |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weller, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heimberger, Amy B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Khasraw, Mustafa |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 28(2022), 4, Seite 585-593 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a Designing clinical trials for combination immunotherapy a framework for glioblastoma |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:4 |g pages:585-593 |g extent:9 |a Designing clinical trials for combination immunotherapy a framework for glioblastoma |
| 856 | 4 | 0 | |u https://doi.org/10.1158/1078-0432.CCR-21-2681 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://aacrjournals.org/clincancerres/article/28/4/585/678113/Designing-Clinical-Trials-for-Combination |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240527 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 121627780 |a Platten, Michael |m 121627780:Platten, Michael |d 60000 |d 62700 |e 60000PP121627780 |e 62700PP121627780 |k 0/60000/ |k 1/60000/62700/ |p 7 | ||
| 999 | |a KXP-PPN1889905100 |e 4529986446 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"15 February 2022"}],"recId":"1889905100","id":{"doi":["10.1158/1078-0432.CCR-21-2681"],"eki":["1889905100"]},"person":[{"given":"Kirit","family":"Singh","display":"Singh, Kirit","role":"aut"},{"role":"aut","display":"Batich, Kristen A.","family":"Batich","given":"Kristen A."},{"given":"Patrick Y.","role":"aut","family":"Wen","display":"Wen, Patrick Y."},{"given":"Aaron C.","role":"aut","family":"Tan","display":"Tan, Aaron C."},{"given":"Stephen J.","family":"Bagley","display":"Bagley, Stephen J.","role":"aut"},{"given":"Michael","display":"Lim, Michael","family":"Lim","role":"aut"},{"display":"Platten, Michael","family":"Platten","role":"aut","given":"Michael"},{"family":"Colman","display":"Colman, Howard","role":"aut","given":"Howard"},{"given":"David M.","role":"aut","display":"Ashley, David M.","family":"Ashley"},{"display":"Chang, Susan M.","family":"Chang","role":"aut","given":"Susan M."},{"given":"Rifaquat","display":"Rahman, Rifaquat","family":"Rahman","role":"aut"},{"role":"aut","display":"Galanis, Evanthia","family":"Galanis","given":"Evanthia"},{"given":"Alireza","family":"Mansouri","display":"Mansouri, Alireza","role":"aut"},{"given":"Vinay K.","family":"Puduvalli","display":"Puduvalli, Vinay K.","role":"aut"},{"display":"Reardon, David A.","family":"Reardon","role":"aut","given":"David A."},{"role":"aut","display":"Sahebjam, Solmaz","family":"Sahebjam","given":"Solmaz"},{"given":"John H.","role":"aut","family":"Sampson","display":"Sampson, John H."},{"given":"John","role":"aut","family":"Simes","display":"Simes, John"},{"display":"Berry, Donald A.","family":"Berry","role":"aut","given":"Donald A."},{"given":"Gelareh","display":"Zadeh, Gelareh","family":"Zadeh","role":"aut"},{"given":"Tim F.","role":"aut","display":"Cloughesy, Tim F.","family":"Cloughesy"},{"display":"Mehta, Minesh P.","family":"Mehta","role":"aut","given":"Minesh P."},{"display":"Piantadosi, Steven","family":"Piantadosi","role":"aut","given":"Steven"},{"given":"Michael","family":"Weller","display":"Weller, Michael","role":"aut"},{"role":"aut","family":"Heimberger","display":"Heimberger, Amy B.","given":"Amy B."},{"given":"Mustafa","role":"aut","display":"Khasraw, Mustafa","family":"Khasraw"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"pubHistory":["1.1995 -"],"disp":"Designing clinical trials for combination immunotherapy a framework for glioblastomaClinical cancer research","part":{"issue":"4","extent":"9","year":"2022","text":"28(2022), 4, Seite 585-593","volume":"28","pages":"585-593"},"recId":"325489971","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title":"Clinical cancer research","title_sort":"Clinical cancer research"}],"name":{"displayForm":["American Association for Cancer Research"]},"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"id":{"issn":["1557-3265"],"eki":["325489971"],"zdb":["2036787-9"]},"origin":[{"dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisherPlace":"Philadelphia, Pa. [u.a.]","publisher":"AACR"}]}],"physDesc":[{"noteIll":"Illustrationen","extent":"9 S."}],"title":[{"title_sort":"Designing clinical trials for combination immunotherapy","title":"Designing clinical trials for combination immunotherapy","subtitle":"a framework for glioblastoma"}],"language":["eng"],"note":["Gesehen am 27.05.2024"],"name":{"displayForm":["Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi, Michael Weller, Amy B. Heimberger, and Mustafa Khasraw"]}} | ||
| SRT | |a SINGHKIRITDESIGNINGC1520 | ||